rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-11-30
|
pubmed:databankReference |
|
pubmed:abstractText |
Antioxidants have been shown to ameliorate lipid-induced impairment of insulin action and beta cell function, both in vitro and in animal studies. The aim of the present study was to examine the effects of two orally administered antioxidants, N-acetylcysteine (NAC) and taurine (TAU), on lipotoxicity in humans.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0012-186X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-46
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18026714-Acetylcysteine,
pubmed-meshheading:18026714-Administration, Oral,
pubmed-meshheading:18026714-Adult,
pubmed-meshheading:18026714-Diabetes Mellitus,
pubmed-meshheading:18026714-Fatty Acids, Nonesterified,
pubmed-meshheading:18026714-Free Radical Scavengers,
pubmed-meshheading:18026714-Humans,
pubmed-meshheading:18026714-Insulin,
pubmed-meshheading:18026714-Insulin-Secreting Cells,
pubmed-meshheading:18026714-Lipids,
pubmed-meshheading:18026714-Male,
pubmed-meshheading:18026714-Middle Aged,
pubmed-meshheading:18026714-Obesity,
pubmed-meshheading:18026714-Overweight,
pubmed-meshheading:18026714-Taurine
|
pubmed:year |
2008
|
pubmed:articleTitle |
Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men.
|
pubmed:affiliation |
Department of Medicine, University of Toronto, Toronto, ON, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|